Expression and 7-day time course of circulating microRNAs in septic patients treated with nephrotoxic antibiotic agents

dc.contributor.authorPetejová, Naděžda
dc.contributor.authorMartínek, Arnošt
dc.contributor.authorZadražil, Josef
dc.contributor.authorKlementa, Viktor
dc.contributor.authorPřibylová, Lenka
dc.contributor.authorBriš, Radim
dc.contributor.authorKáňová, Marcela
dc.contributor.authorŠigutová, Radka
dc.contributor.authorKacířová, Ivana
dc.contributor.authorŠvagera, Zdeněk
dc.contributor.authorBače, Eva
dc.contributor.authorStejskal, David
dc.date.accessioned2022-06-15T11:43:54Z
dc.date.available2022-06-15T11:43:54Z
dc.date.issued2022
dc.description.abstractBackground: Through regulation of signaling pathways, microRNAs (miRNAs) can be involved in sepsis and associated organ dysfunction. The aims of this study were to track the 7-day time course of blood miRNAs in patients with sepsis treated with vancomycin, gentamicin, or a non-nephrotoxic antibiotic and miRNA associations with neutrophil gelatinase-associated lipokalin (NGAL), creatinine, procalcitonin, interleukin-6, and acute kidney injury (AKI) stage. Methods: Of 46 adult patients, 7 were on vancomycin, 20 on gentamicin, and 19 on another antibiotic. Blood samples were collected on days 1, 4, and 7 of treatment, and miRNAs were identified using quantitative reverse transcription PCR. Results: The results showed no relationship between miRNA levels and biochemical variables on day 1. By day 7 of gentamicin treatment miR-15a-5p provided good discrimination between AKI and non-AKI (area under curve, 0.828). In patients taking vancomycin, miR-155-5p and miR-192-5p positively correlated with creatinine and NGAL values, and miR-192-5p and miR-423-5p positively correlated with procalcitonin and interleukin-6 in patients treated with a nonnephrotoxic antibiotic. In patients together we found positive correlation between miR-155-5p and miR-423-5p and all biochemical markers. Conclusion: The results suggest that these four miRNAs may serve as diagnostic or therapeutic tool in sepsis, renal injury and nephrotoxic treatment.cs
dc.description.firstpageart. no. 111cs
dc.description.issue1cs
dc.description.sourceWeb of Sciencecs
dc.description.volume23cs
dc.identifier.citationBMC Nephrology. 2022, vol. 23, issue 1, art. no. 111.cs
dc.identifier.doi10.1186/s12882-022-02726-6
dc.identifier.issn1471-2369
dc.identifier.urihttp://hdl.handle.net/10084/146281
dc.identifier.wos000770762200002
dc.language.isoencs
dc.publisherSpringer Naturecs
dc.relation.ispartofseriesBMC Nephrologycs
dc.relation.urihttps://doi.org/10.1186/s12882-022-02726-6cs
dc.rightsCopyright © 2022, The Author(s)cs
dc.rights.accessopenAccesscs
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/cs
dc.subjectacute kidney injurycs
dc.subjectgentamicincs
dc.subjectmicroRNAcs
dc.subjectnephrotoxicitycs
dc.subjectsepsiscs
dc.subjectvancomycincs
dc.titleExpression and 7-day time course of circulating microRNAs in septic patients treated with nephrotoxic antibiotic agentscs
dc.typearticlecs
dc.type.statusPeer-reviewedcs
dc.type.versionpublishedVersioncs

Files

Original bundle

Now showing 1 - 1 out of 1 results
Loading...
Thumbnail Image
Name:
1471-2369-2022v23i1an111.pdf
Size:
1.46 MB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 out of 1 results
Loading...
Thumbnail Image
Name:
license.txt
Size:
718 B
Format:
Item-specific license agreed upon to submission
Description: